Scientific Catalyst Intelligence
Monitor biotech catalysts from
public data — automatically.
BioCatalyst Radar ingests ClinicalTrials.gov, PubMed, SEC EDGAR, and openFDA continuously, scores signal cards by evidence strength and urgency, and surfaces monitoring priorities. Not personalised investment advice.
What BioCatalyst Radar does
Automated source-linked catalyst monitoring from public biotech data.
📡 Live signal monitoring
Continuous ingestion from 7+ public sources. Field-level change detection.
Signal cards scored across 5 dimensions: evidence strength, urgency, market relevance,
confidence, and safety risk.
🔬 Source-linked evidence
Every signal card links to its public source URL. No black-box scores.
Deterministic, auditable scoring — no LLM required for core signals.
📋 Decision Lab
Monitoring priority ranking with uncertainty notes and historical reaction context.
All signals require human review. Not a recommendation to trade.
📅 Catalyst Calendar
Clinical trial milestone tracker: upcoming data readouts, trial status changes,
FDA decision dates across monitored companies.
⚠️ Safety Signals
Signals flagged for elevated safety risk based on adverse event data and
detected changes. Separated from catalyst priority ranking.
📊 Historical Context
Historical reaction context for known catalyst types — median observed reactions,
phase distribution, and volatility flags. Does not predict future outcomes.
Early access now open
BioCatalyst Radar is in private beta. Request access to the Pro dashboard — full signal cards, Decision Lab, and Catalyst Calendar.
Request Early Access